CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a miniaturized cell screening system that uses primary and stem cells for drug discovery. By reducing reagent and cell consumption, it aims to enhance personalized medicine and improve the relevance of pre-clinical testing while lowering costs.
Current cell screening systems based on microtiter plates are mainly used to perform drug discovery experiments.
However, performing a larger number of therapeutic tests on patient derived (primary) cells is yet impossible due to the high consumption of reagents and cells when using microplates.
In the clinical context, personalized drug screenings for optimal medical treatment are not possible due to the scarcity of precious primary cells.
In pre-clinical drug discovery, the extremely high cost…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
